Publications by authors named "Roger Slavik"

Claim this Profile
T
Tandem Isotope Therapy with Ac- and Lu-PSMA-617 in a Murine Model of Prostate Cancer.
Catherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik

J Nucl Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous cardiac sympathetic innervation gradients promote arrhythmogenesis in murine dilated cardiomyopathy.
Al-Hassan J Dajani, Michael B Liu, Michael A Olaopa, Lucian Cao, Carla Valenzuela-Ripoll, Roger Slavik

JCI Insight· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225.
Catherine Meyer, Vikas Prasad, Andreea Stuparu, Peter Kletting, Gerhard Glatting, Roger Slavik

EJNMMI Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study.
Christine E Mona, Matthias R Benz, Firas Hikmat, Tristan R Grogan, Katharina Lueckerath, Roger Slavik

J Nucl Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort.
Jeremie Calais, Andrei Gafita, Matthias Eiber, Wesley R Armstrong, Jeannine Gartmann, Roger Slavik

J Nucl Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer.
Andreea D Stuparu, Joseph R Capri, Catherine A L Meyer, Thuc M Le, Susan L Evans-Axelsson, Roger Slavik

J Nucl Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput radio-TLC analysis.
Jia Wang, Alejandra Rios, Ksenia Lisova, Roger Slavik, Arion F Chatziioannou

Nucl Med Biol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study.
Andreea D Stuparu, Catherine A L Meyer, Susan L Evans-Axelsson, Katharina Lückerath, Liu H Wei, Roger Slavik

Theranostics· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial.
Wolfgang P Fendler, Jeremie Calais, Matthias Eiber, Jeffrey P Simko, John Kurhanewicz, Roger Slavik

Eur J Nucl Med Mol Imaging· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership.
Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha

J Nucl Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
Wolfgang P Fendler, Justin Ferdinandus, Johannes Czernin, Matthias Eiber, Robert R Flavell, Roger Slavik

J Nucl Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation Dosimetry and Biodistribution of Ga-FAPI-46 PET Imaging in Cancer Patients.
Catherine Meyer, Magnus Dahlbom, Thomas Lindner, Sebastien Vauclin, Christine Mona, Roger Slavik

J Nucl Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity.
Kyle Current, Catherine Meyer, Clara E Magyar, Christine E Mona, Joel Almajano, Roger Slavik

Clin Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP Compliance.
Shaojun Zhu, Sherly Mosessian, Kurt Kroeger, Saman Sadeghi, Roger Slavik

Mol Imaging Biol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Modifier Screen Reveals Secondary Targets of Protein Kinase Inhibitors within Nucleotide Metabolism.
Evan R Abt, Ethan W Rosser, Matthew A Durst, Vincent Lok, Soumya Poddar, Roger Slavik

Cell Chem Biol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-GBq production of the radiotracer [F]fallypride in a droplet microreactor.
Jia Wang, Philip H Chao, Roger Slavik, R Michael van Dam

RSC Adv· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Search for an Alternative to [Ga]Ga-DOTA-TATE in Neuroendocrine Tumor Theranostics: Current State of F-labeled Somatostatin Analog Development.
Christopher M Waldmann, Andreea D Stuparu, R Michael van Dam, Roger Slavik

Theranostics· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-fluciclovine PET-CT and Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.
Jeremie Calais, Francesco Ceci, Matthias Eiber, Thomas A Hope, Michael S Hofman, Roger Slavik

Lancet Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.
Wolfgang P Fendler, Jeremie Calais, Matthias Eiber, Robert R Flavell, Ashley Mishoe, Roger Slavik

JAMA Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer.
Katharina Lückerath, Liu Wei, Wolfgang P Fendler, Susan Evans-Axelsson, Andreea D Stuparu, Roger Slavik

EJNMMI Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production.
Eric Schopf, Christopher M Waldmann, Jeffrey Collins, Christopher Drake, Roger Slavik

J Vis Exp· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection Threshold and Reproducibility of Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer.
Katharina Lückerath, Andreea D Stuparu, Liu Wei, Woosuk Kim, Caius G Radu, Roger Slavik

J Nucl Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microscale radiosynthesis, preclinical imaging and dosimetry study of [F]AMBF-TATE: A potential PET tracer for clinical imaging of somatostatin receptors.
Ksenia Lisova, Maxim Sergeev, Susan Evans-Axelsson, Andreea D Stuparu, Seval Beykan, Roger Slavik

Nucl Med Biol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence.
Jeremie Calais, Wolfgang P Fendler, Matthias Eiber, Jeannine Gartmann, Fang-I Chu, Roger Slavik

J Nucl Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of diverse PET probes with limited resources: 24 F-labeled compounds prepared with a single radiosynthesizer.
Jeffrey Collins, Christopher M Waldmann, Christopher Drake, Roger Slavik, Noel S Ha

Proc Natl Acad Sci U S A· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis